National vaccine preparedness against pandemic influenza

Folkehelseinstituttet

The Norwegian Institute of Public Health is carrying out an open tender contest for the procurement of vaccine preparedness against pandemic influenza on behalf of the Ministry of Health and Care Services. The objective of the procurement is to ensure that Norway's residents have access to a vaccine in the event of an influenza pandemic occurring in the contract period.
The procurement shall be carried out as an open tender contest in accordance with the Public Procurement Act Parts 1 and 3. The procurement will be carried out as an open tender competition.

Frist

Fristen for mottak av tilbud var 2022-05-19. Anskaffelsen ble publisert 2022-04-19.

Leverandører

Følgende leverandører er nevnt i tildelingsbeslutninger eller andre anskaffelsesdokumenter:

Hvem? Hva? Hvor?
Anskaffelseshistorikk
Dato Dokument
2022-04-19 Kunngjøring av konkurranse
2022-07-14 Kunngjøring om tildeling av kontrakt
Kunngjøring av konkurranse (2022-04-19)
Gjenstand
Anskaffelsens omfang
Tittel: Influenza vaccines
Referansenummer: 22/01369
Kort beskrivelse:
The Norwegian Institute of Public Health is carrying out an open tender contest for the procurement of vaccine preparedness against pandemic influenza on behalf of the Ministry of Health and Care Services. The objective of the procurement is to ensure that Norway's residents have access to a vaccine in the event of an influenza pandemic occurring in the contract period. The procurement shall be carried out as an open tender contest in accordance with the Public Procurement Act Parts 1 and 3. The procurement will be carried out as an open tender competition.
Vis mer
Metadata for kunngjøring
Originalspråk: engelsk 🗣️
Dokumenttype: Kunngjøring av konkurranse
Kontraktens art: Varer
Forskrift: Det europeiske økonomiske samarbeidsområdet (EØS), med deltakelse av GPA-land
Felles innkjøpsordliste (CPV)
Kode: Influensavaksine 📦
Tilleggs-CPV: Vaksiner 📦
Influensavaksine 📦
Utførelsessted
NUTS-region: Norge 🏙️

Prosedyre
Prosedyretype: Åpen anbudskonkurranse
Tilbudstype: Innlevering for alle delkontrakter
Tildelingskriterier
Det mest økonomisk fordelaktige tilbudet

Oppdragsgiver
Identitet
Land: Norge 🇳🇴
Type tildelende myndighet: Departement eller annen nasjonal eller føderal myndighet
Navn på tildelende myndighet: Folkehelseinstituttet
Postadresse: Lovisenberggata 8
Postnummer: 0456
Poststed: Oslo
Kontakt
Internettadresse: http://www.fhi.no 🌏
E-post: ole.andreas.fuglesang@fhi.no 📧
Telefon: +47 21076629 📞
URL for dokumenter: http://eu.eu-supply.com/app/rfq/rwlentrance_s.asp?PID=329368&B=DFO 🌏
URL for deltakelse: http://eu.eu-supply.com/app/rfq/rwlentrance_s.asp?PID=329368&B=DFO 🌏

Referanse
Datoer
Sendt dato: 2022-04-19 📅
Innleveringsfrist: 2022-05-19 📅
Publiseringsdato: 2022-04-22 📅
Identifikatorer
Kunngjøringsnummer: 2022/S 079-214046
OJ-S-utgave: 79
Tilleggsinformasjon
Two employees from the contracting authority with a user licence in the tender management system will log in and open the tenders.

Gjenstand
Anskaffelsens omfang
Kort beskrivelse:
The Norwegian Institute of Public Health is carrying out an open tender contest for the procurement of vaccine preparedness against pandemic influenza on behalf of the Ministry of Health and Care Services. The objective of the procurement is to ensure that Norway's residents have access to a vaccine in the event of an influenza pandemic occurring in the contract period.
Vis mer
The procurement shall be carried out as an open tender contest in accordance with the Public Procurement Act Parts 1 and 3. The procurement will be carried out as an open tender competition.
Estimert totalverdi: 750 000 000 NOK 💰
Største antall delkontrakter per tilbyder: 1
Tittel på delkontrakt: National vaccine preparedness against pandemic influenza - 5 525 306 doses.
Delkontraktnummer: 1
Kort beskrivelse:
The Norwegian Institute of Public Health is carrying out an open tender contest for the procurement of vaccine preparedness against pandemic influenza on behalf of the Ministry of Health and Care Services. The objective of the procurement is to ensure that Norway's residents have access to vaccines in the event of an influenza pandemic occurring during the contract period.
Vis mer
Based on a population of 5 525 306 people (Statistics Norway's estimate for Norway's population in 2026), and that a two-dose regimen may be necessary to ensure full immunity in the entire population, the total number of vaccine doses against pandemic influenza is 11 050 612 doses.
Vis mer
As described in the Call for Tender section 1.4, approximately 3.9 million doses have already been covered through the European Health Emergency Preparedness and Response Authority (HERA). The remaining need is consequently 7 101 946 doses.
The Norwegian Institute of Public Health intends to enter into contracts with two suppliers. To ensure the best possible security of supply, a limit of 50% of the total need of 11 050 612 doses has been decided for a single supplier. This means that a supplier who already has a contract for the delivery of a vaccine against pandemic influenza to Norway, can only be assigned a limited number of doses to ensure that this supplier does not exceed the limit of 50% of the total need.
Vis mer
The 7 101 946 vaccine doses will be divided between two contracts. One contract includes the delivery of 5 525 306 doses (50%) and the other of 1 576 640 doses, which is the remaining number of doses needed to achieve 100% coverage of the total need.
Vis mer
Each supplier can only be awarded one contract. Tenderers are allowed to offer a set of prices (preparedness fee and price per vaccine) for each volume. It is not mandatory to offer prices for both volumes. A tenderer can, for example, choose to submit tenders for only one volume. A tenderer that has an ongoing contract for the delivery of vaccine doses against pandemic influenza to Norway can only submit tenders for the delivery of 1 576 640 doses.
Vis mer
The Norwegian Institute of Public Health will award a contract for the reservation of 5 525 306 vaccine doses to the tenderer who gives the best price-quality ratio for this volume. (Supplier no. 1)
A contract of 1 576 640 vaccine doses will then be awarded to one of the remaining suppliers who has offered the best price-quality ratio for this volume (Supplier no. 2).
The contracts have an option for delivering vaccines against pandemic influenza in the contract period. The number of doses that the Norwegian Institute of Public Health will order under each volume will depend on the chosen immunization regimen and the expected severity of the pandemic.
Vis mer
The Norwegian Institute of Public Health emphasises that the procurement may be dependent on final approval from the Ministry of Health and Care Services and the Norwegian Parliament. The invitation to tender may be cancelled if such approval is not obtained.
Vis mer
A comprehensive description of the supplier requirements is given in the Call for Tender.
Estimert verdi eksklusive mva: 583 499 156 NOK 💰
Varighet: 48 måneder
Beskrivelse av opsjoner:
The contracts have an option for delivering vaccines against pandemic influenza in the contract period. The number of doses that the Norwegian Institute of Public Health will order under each volume will depend on the chosen immunization regimen and the expected severity of the pandemic.
Vis mer
Tittel på delkontrakt: National vaccine preparedness against pandemic influenza - 1 576 640 doses.
Delkontraktnummer: 2
Kort beskrivelse:
The Norwegian Institute of Public Health intends to enter into contract with two suppliers. To ensure the best possible security of supply, a limit of 50% of the total need of 11 050 612 doses has been decided for a single supplier. This means that a supplier who already has a contract for the delivery of a vaccine against pandemic influenza to Norway, can only be assigned a limited number of doses to ensure that this supplier does not exceed the limit of 50% of the total need.
Vis mer
Each supplier can only be awarded one contract. Tenderers are allowed to offer a set of prices (preparedness fee and price per vaccine) for each volume. It is not mandatory to offer prices for both volumes. A tenderer can, for example, choose to submit tenders for only one volume. A tenderer who has an ongoing contract for the delivery of vaccine doses against pandemic influenza to Norway can only submit tenders for the delivery of 1 576 640 doses.
Vis mer
The Norwegian Institute of Public Health will award a contract for the reservation of 5 525 306 vaccine doses to the tenderer who gives the best price-quality ratio for this volume. (Supplier no. 1.)
Estimert verdi eksklusive mva: 166 500 843 NOK 💰
Beskrivelse av opsjoner:
The contracts have an option for delivering a vaccine against pandemic influenza in the contract period. The number of doses that the Norwegian Institute of Public Health will order under each volume will depend on the chosen immunization regimen and the expected severity of the pandemic.
Vis mer
Utførelsessted
Hovedsted eller utførelsessted: Oslo

Juridisk, økonomisk, finansiell og teknisk informasjon
Vilkår for deltakelse
Egnethet til å utøve yrkesvirksomheten:
Tenderers must be registered in a company register, professional register or a trade register in the country where the tenderer is established.
Teknisk og faglig kapasitet:
The tenderer must have the requisite permissions to be able to fulfil the contract.
The supplier shall have sufficient production capacity for the delivery of the required volume of influenza vaccines.
The supplier must have a marketing authorisation (MA) for tetravalent seasonal influenza vaccine in the EU / EEA, issued via a central procedure.
The supplier must have an active production of tetravalent seasonal influenza vaccine.
Kontraktutførelse
Vilkår for kontraktoppfyllelse: See the attached Advance Purchase Agreement.

Prosedyre
Rettslig grunnlag: 32014L0024
Tidspunkt for mottak av tilbud: 14:00
Språk som tilbud eller forespørsler om deltakelse kan sendes inn på: engelsk 🗣️
norsk 🗣️
Tilbudets gyldighetsperiode: 2022-07-19 📅
Dato for åpning av tilbud: 2022-05-19 📅
Tidspunkt for åpning av tilbud: 14:00
Sted: Electronic opening in the Norwegian Institute of Public Health’s tender management system (Norwegian: KGV).
Tilleggsinformasjon:
Two employees from the contracting authority with a user licence in the tender management system will log in and open the tenders.

Oppdragsgiver
Identitet
Nasjonalt registreringsnummer: 983 744 516
Kontakt
Kontaktpunkt: Ole Andreas Fuglesang
Adresse til kjøperprofilen: https://eu.eu-supply.com/ctm/Company/CompanyInformation/Index/346372 🌏
URL for dokumenter: http://eu.eu-supply.com/app/rfq/rwlentrance_s.asp?PID=329368&B=DFO 🌏

Utfyllende informasjon
Klageinstans
Navn: Oslo tingrett
Postadresse: Postboks 2106 Vika
Poststed: Oslo
Postnummer: 0125
Land: Norge 🇳🇴
Telefon: +47 22035200 📞
E-post: oslo.tingrett@domstol.no 📧
Internettadresse: https://www.domstol.no/Enkelt-domstol/oslotingrett/ 🌏
Kilde: OJS 2022/S 079-214046 (2022-04-19)
Kunngjøring om tildeling av kontrakt (2022-07-14)
Gjenstand
Anskaffelsens omfang
Kort beskrivelse:
The Norwegian Institute of Public Health has carried out an open tender contest for the procurement of vaccine preparedness against pandemic influenza on behalf of the Ministry of Health and Care Services. The objective of the procurement was to ensure that Norway's residents have access to vaccines in the event of an influenza pandemic occurring during the contract period. The procurement was carried out as an open tender contest in accordance with the Public Procurement Act Parts 1 and 3. The procurement was carried out as an open tender competition. A contract was awarded for one lot for the delivery of 5 525 306 doses of vaccine.
Vis mer
Totalverdi for anskaffelsen: 750 000 000 NOK 💰
Metadata for kunngjøring
Dokumenttype: Kunngjøring om tildeling av kontrakt

Prosedyre
Tilbudstype: Ikke aktuelt

Oppdragsgiver
Kontakt
E-post: oleandreas.fuglesang@fhi.no 📧

Referanse
Datoer
Sendt dato: 2022-07-14 📅
Publiseringsdato: 2022-07-19 📅
Identifikatorer
Kunngjøringsnummer: 2022/S 137-393183
Refererer til kunngjøring: 2022/S 079-214046
OJ-S-utgave: 137
Tilleggsinformasjon
The quality criterion was divided in to sub-criterias: Pharmaceutical quality (50%) Delivery (50%)

Gjenstand
Anskaffelsens omfang
Kort beskrivelse:
The Norwegian Institute of Public Health has carried out an open tender contest for the procurement of vaccine preparedness against pandemic influenza on behalf of the Ministry of Health and Care Services. The objective of the procurement was to ensure that Norway's residents have access to vaccines in the event of an influenza pandemic occurring during the contract period.
Vis mer
The procurement was carried out as an open tender contest in accordance with the Public Procurement Act Parts 1 and 3. The procurement was carried out as an open tender competition.
A contract was awarded for one lot for the delivery of 5 525 306 doses of vaccine.
In accordance with the Call for Tender's section 1.4, approximately 3.9 million doses were already covered through the European Health Emergency Preparedness and Response Authority (HERA) at the time of the publication of the Call for Tender. The remaining needs were consequently 7 101 946 doses.
Vis mer
The Norwegian Institute of Public Health intention was to enter into agreements with two suppliers. To ensure the best possible security of supply, a limit of 50% of the total need of 11 050 612 doses was decided for a single supplier. This means that a supplier who already has a contract for the delivery of a vaccine against pandemic influenza to Norway, can only be assigned a limited number of doses to ensure that this supplier does not exceed the limit of 50% of the total need.
Vis mer
Each supplier can only be awarded one contract. Tenderers were allowed to present a set of prices (preparedness fee and price per vaccine) for each volume. It was not mandatory to offer prices for both volumes. A tenderer could, for example, choose to submit tenders for only one volume. A tenderer who was already awarded a contract for the delivery of vaccine doses against pandemic influenza to Norway was only allowed to submit tenders for the delivery of 1 576 640 doses against the contract.
Vis mer
The Norwegian Institute of Public Health will award a contract for the reservation of 5 525 306 vaccine doses to the tenderer who presented the best price-quality ratio for this volume. (Supplier no. 1.)
A contract of 1 576 640 vaccine doses should then be awarded to one of the remaining suppliers who had given the best price-quality ratio for this volume (Supplier no. 2).
The contracts have an option for delivering a vaccine against pandemic influenza in the contract period. The number of doses that the Norwegian Institute of Public Health will order under each volume will depend on the chosen immunization regimen and the expected severity of the pandemic.
Vis mer
Tilleggsinformasjon:
The quality criterion was divided in to sub-criterias:
Pharmaceutical quality (50%)
Delivery (50%)

Prosedyre
Tildelingskriterier
Kvalitetskriterium (navn): Quality
Kvalitetskriterium (vekting): 60
Pris (vekting): 40

Tildeling av kontrakt
Dato for kontraktinngåelse: 2022-07-11 📅
Navn: Seqirus UK Limited
Nasjonalt registreringsnummer: N/a
Postadresse: 29 Market St
Poststed: Maidenhead
Postnummer: SL6 8AA
Land: Storbritannia 🇬🇧
Totalverdi for anskaffelsen: 640 000 000 NOK 💰
Informasjon om tilbud
Antall mottatte tilbud: 1

Referanse
Tilleggsinformasjon
Tenders were not received from other suppliers. Only contract for one lot was therefore awarded.
The selected vaccine is Seqirus Foclivia
Kilde: OJS 2022/S 137-393183 (2022-07-14)
Nye anskaffelser i relaterte kategorier 🆕
Relaterte søk 🔍
Produkter/tjenester:
Medisinsk utstyr, legemidler og utstyr... Farmasøytiske produkter Antiinfektive midler for systemisk bruk,... Antiinfektive midler for systemisk bruk Vaksiner Influensavaksine